Ajanta Pharma Limited (BOM:532331)
India · Delayed Price · Currency is INR 3,383.95
+17.50 (0.52%)
At close: Jul 27, 2026
Ajanta Pharma Stock Forecast
Stock Price Forecast
According to 14 analysts polled by S&P Global, Ajanta Pharma stock has a consensus rating of "Buy" and an average price target of ₹3,343. The average 1-year stock price forecast is 1.20% lower than the current stock price, while the lowest is ₹2,615 (-22.72%) and the highest is ₹3,950 (+16.73%).
Price Target: ₹3,343 (-1.20%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Ajanta Pharma stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Apr '26 | May '26 | Jun '26 | Jul '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 9 | 9 | 9 | 11 | 11 | 11 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 12 | 12 | 12 | 14 | 14 | 14 |
Financial Forecast
Revenue This Year
62.66B
from 54.53B
Increased by 14.92%
Revenue Next Year
70.34B
from 62.66B
Increased by 12.25%
EPS This Year
98.25
from 84.51
Increased by 16.26%
EPS Next Year
113.84
from 98.25
Increased by 15.87%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is INR.